Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CBLB | Q13191 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL740046 | 0.80 | CYP2D6 (0.38) | CBLBTSHR | |
| SCHEMBL15934939 | 0.78 | USP2 (0.40) | USP2CYP3A4MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL19822065 | 0.77 | ALOX15 (0.40) | ALDH1A1CBLB | |
| SCHEMBL11131009 | 0.76 | TSHR (0.41) | MAPTSMN1; SMN2ALDH1A1CBLBTSHR | |
| SCHEMBL11400607 | 0.76 | CBLB (0.37) | MAPTSMN1; SMN2CBLBTSHRCHRM2 | |
| SCHEMBL6864349 | 0.76 | TSHR (0.45) | USP2CYP3A4MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL13764173 | 0.74 | ALDH1A1 (0.38) | USP2CYP3A4MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL7163891 | 0.73 | SMN1; SMN2 (0.37) | USP2CYP3A4MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL29008692 | 0.73 | TRPV1 (0.40) | USP2CYP3A4MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL10978626 | 0.73 | GAA (0.34) | CBLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | THE TRUSTEES OF BOSTON COLLEGE | 2016-06-16 | — | — | US | disclosed |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | THE TRUSTEES OF BOSTON COLLEGE | 2016-06-16 | — | — | US | disclosed |
| US-20100292486-A1 | RECYCLABLE METATHESIS CATALYSTS | HOVEYDA AMIR H | 2010-11-18 | — | — | US | disclosed |
| US-20100292486-A1 | RECYCLABLE METATHESIS CATALYSTS | HOVEYDA AMIR H | 2010-11-18 | — | — | US | disclosed |
| US-7723255-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2010-05-25 | — | — | US | disclosed |
| US-7723255-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2010-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292486-A1 | RECYCLABLE METATHESIS CATALYSTS | DNMT1, CARM1, ZMYND8 | USP2 1295/4885CYP3A4 220/4885MAPT 2215/4885 |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | DNMT1, CARM1, ZMYND8 | USP2 1295/4885CYP3A4 220/4885MAPT 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.